areference test in epidemiological studies. II. Aprobabilistic model for the comparison of diagnosticmethods. American Journal of Epidemiology 83: 593-602,1966.19. Guan LR. Current status of kala-azar and vector control inChina. Bulletin of the World Health Organization 69: 595-601,1991.20. Gupta S. Return of kala-azar. Journal of Indian MedicalAssociation 65: 89-90, 1975.21. Hantson P, Luyasu S, Haufroid V, Lambert M. Antimonyexcretion in a patient with renal impairment during meglumineantimoniate therapy. Pharmacotherapy 20: 1141-1143, 2000.22. Lacerda, M. The Brazilian leishmaniasis control program.Memorias do Instituto Oswaldo Cruz 89: 489-495, 1994.23. Leonard A, Gerber GB. Mutagenicity, carcinogenicity andteratogenicity of antimony compounds. Mutation Research366:1-8, 1996.24. Lu CC, Chung HL, Ling CC, Wu CC, Wang CC, Chiang YT,Hsu WF. New Chinas achievements in the kala-azar treatmentand prevention of kala-azar. Chinese Medical Journal 78: 91-99, 1955.25. Magalhaes PA, Mayrink W, Costa CA, Melo MN, Dias M,Batista SM, Michalick MSM, Williams P. Calazar na Zona doRio Doce Minas Gerais. Resultados de medidasprofilaticas. Revista do Instituto de Medicina Tropical de SaoPaulo 22: 197-202, 1980.26. Maguire JH, Costa CH, Lamounier D, Beck LR, Lobitz B,Dister D, Wood B. Remote sensing and geographicinformation systems technology applied to infectiousdisease transmission of Leishmania chagasi in Teresina,Piaui, Brazil. In: Sixth Annual Meeting NIAID InternationalCenters for Tropical Disease Research, US Department ofHealth and Human Services, National Institutes of Health,1997.27. Ministerio da Saude. Controle, Diagnostico e tratamento daleishmaniose visceral. Fundacao Nacional de Saude, Brasilia,1999.28. Molina R, Amela C, Nieto J, San Andres M, Gonzalez F, CastilloJA, Lucientes J, Alvar J. infectivity of dogs naturally infectedwith Leishmania infantum to colonized Phlebotomusperniciosus. Transactions of the Royal Society of TropicalMedicine and Hygiene 88: 491-493, 1994.29. Monteiro P, Lacerda MM, Arias JR. Controle da leishmaniosevisceral no Brasil. Revista da Sociedade Brasileira de MedicinaTropical 27 (supl III): 67-72, 1994.30. Nascimento MRSB. Epidemiologia da leishmaniose visceral naIlha de Sao Luis, Maranhao Brasil: analise da dinamica detransmissao e dos fatores de risco relacionados aodesenvolvimento da doenca. Tese de Doutorado. EscolaPaulista de Medicina, Sao Paulo, SP, 1996.31. Seaman J, Mercer AJ, Sondorp E. The epidemic of visceralleishmaniasis in Western Upper Nile, Southern Sudan: courseand impact from 1984 to 1994. International Journal odEpidemiology 25: 862-871, 1996.32. Sherlock IA, Miranda JC , Sadigursky M, Grimaldi G. Naturalinfection of the opossum Didelphis marsupialis (MarsupialiaDidelphidae) with Leishmania chagasi in Brazil. Memorias doInstituto Oswaldo Cruz 79: 511, 1984.33. Sobel JD. Use of antifungal drugs in pregnancy: a focus onsafety. Drug Safety 23: 77-85, 2000.34. Thakur CP, Singh RK, Hassan SM, Kumar R, Narain S, KumarA. Amphotericin deoxycholate treatment of visceralleishmaniasis with newer modes of administration andprecautions: a study of 938 cases. Transactions of the RoyalSociety of Tropical Medicine and Hygiene 93: 319-323, 1999.35. Weinstein MC, Fineberg HV, Elstein AS, Frazier HS,Neuhauser D, Neutra RR, McNeil BJ. Clinical decision analysis.Saunders, Philadelphia, 1980.REPRODUZIDO POR CRISTIANE DE MELO PROFESSORA DE BIOLOGIA E ALUNA DA ESPECIALIZACAO EM SAUDE PUBLICA DA UECE